Sumitomo Life Insurance Co. boosted its position in Cooper Companies, Inc. (The) (NYSE:COO) by 4.4% during the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 5,485 shares of the medical device company’s stock after buying an additional 233 shares during the period. Sumitomo Life Insurance Co.’s holdings in Cooper Companies, Inc. (The) were worth $1,313,000 at the end of the most recent quarter.

A number of other hedge funds have also recently modified their holdings of COO. BlackRock Inc. boosted its position in shares of Cooper Companies, Inc. (The) by 2,849.1% in the first quarter. BlackRock Inc. now owns 3,071,637 shares of the medical device company’s stock valued at $613,991,000 after buying an additional 2,967,481 shares during the period. Janus Capital Management LLC boosted its position in shares of Cooper Companies, Inc. (The) by 35.7% in the first quarter. Janus Capital Management LLC now owns 1,743,182 shares of the medical device company’s stock valued at $348,441,000 after buying an additional 458,173 shares during the period. Findlay Park Partners LLP bought a new position in shares of Cooper Companies, Inc. (The) during the first quarter valued at about $55,664,000. Vanguard Group Inc. boosted its position in shares of Cooper Companies, Inc. (The) by 5.4% in the first quarter. Vanguard Group Inc. now owns 4,781,732 shares of the medical device company’s stock valued at $955,821,000 after buying an additional 244,531 shares during the period. Finally, MARSHALL WACE ASIA Ltd bought a new position in shares of Cooper Companies, Inc. (The) during the first quarter valued at about $46,885,000. 99.97% of the stock is owned by institutional investors.

Shares of Cooper Companies, Inc. (NYSE:COO) traded up 0.39% during trading on Friday, hitting $240.92. The company had a trading volume of 286,217 shares. The firm has a market capitalization of $11.77 billion, a P/E ratio of 36.12 and a beta of 0.61. The stock’s 50-day moving average is $245.14 and its 200 day moving average is $214.89. Cooper Companies, Inc. has a 52-week low of $158.73 and a 52-week high of $256.39.

Cooper Companies, Inc. (The) (NYSE:COO) last posted its quarterly earnings results on Thursday, June 1st. The medical device company reported $2.50 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.25 by $0.25. Cooper Companies, Inc. (The) had a net margin of 16.02% and a return on equity of 15.88%. The company had revenue of $522.40 million during the quarter, compared to the consensus estimate of $520.71 million. During the same period last year, the firm earned $2.05 EPS. The company’s revenue for the quarter was up 8.0% on a year-over-year basis. Equities research analysts predict that Cooper Companies, Inc. will post $9.63 earnings per share for the current fiscal year.

The business also recently declared a semiannual dividend, which was paid on Monday, August 7th. Stockholders of record on Friday, July 21st were given a dividend of $0.03 per share. The ex-dividend date of this dividend was Wednesday, July 19th. This represents a dividend yield of 0.02%. Cooper Companies, Inc. (The)’s payout ratio is 0.90%.

TRADEMARK VIOLATION WARNING: “Sumitomo Life Insurance Co. Acquires 233 Shares of Cooper Companies, Inc. (The) (NYSE:COO)” was originally reported by TheOlympiaReport and is owned by of TheOlympiaReport. If you are viewing this piece of content on another publication, it was stolen and republished in violation of United States & international trademark & copyright legislation. The legal version of this piece of content can be read at https://theolympiareport.com/2017/08/12/cooper-companies-inc-the-nysecoo-stake-increased-by-sumitomo-life-insurance-co-updated.html.

Several equities analysts have recently issued reports on the company. Oppenheimer Holdings, Inc. set a $225.00 price objective on Cooper Companies, Inc. (The) and gave the company a “hold” rating in a report on Saturday, June 3rd. Guggenheim assumed coverage on Cooper Companies, Inc. (The) in a report on Thursday, June 29th. They issued a “neutral” rating for the company. Jefferies Group LLC reissued a “buy” rating and issued a $250.00 price objective on shares of Cooper Companies, Inc. (The) in a report on Thursday, July 6th. Zacks Investment Research raised Cooper Companies, Inc. (The) from a “hold” rating to a “buy” rating and set a $274.00 price objective for the company in a report on Friday, June 23rd. Finally, Stifel Nicolaus boosted their price objective on Cooper Companies, Inc. (The) from $220.00 to $231.00 and gave the company a “buy” rating in a report on Friday, June 2nd. Four investment analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. Cooper Companies, Inc. (The) presently has a consensus rating of “Buy” and an average target price of $242.00.

In other news, VP Randal Golden sold 1,621 shares of Cooper Companies, Inc. (The) stock in a transaction that occurred on Tuesday, July 11th. The shares were sold at an average price of $243.65, for a total transaction of $394,956.65. Following the completion of the sale, the vice president now directly owns 1,731 shares in the company, valued at approximately $421,758.15. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Stanley Md Zinberg sold 816 shares of Cooper Companies, Inc. (The) stock in a transaction that occurred on Wednesday, June 7th. The shares were sold at an average price of $243.14, for a total transaction of $198,402.24. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 67,331 shares of company stock valued at $16,400,454. Insiders own 1.60% of the company’s stock.

Cooper Companies, Inc. (The) Company Profile

The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.

Institutional Ownership by Quarter for Cooper Companies, Inc. (The) (NYSE:COO)

Receive News & Ratings for Cooper Companies Inc. (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies Inc. (The) and related companies with Analyst Ratings Network's FREE daily email newsletter.